These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3162072)

  • 1. Changes of the striatal 3H-spiperone binding 3-6 weeks after nigrostriatal denervation and after two years.
    Guerin B; Silice C; Mouchet P; Feuerstein C; Demenge P
    Life Sci; 1985 Sep; 37(10):953-61. PubMed ID: 3162072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF; Van het Schip F; Sebens JB; Korf J
    Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I; Snyder SH
    Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
    Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
    Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
    Kozlowski MR; Neve KA; Grisham JE; Marshall JF
    Brain Res; 1983 May; 267(2):301-11. PubMed ID: 6409351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J; Sebens JB
    J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity time course of dopamine antagonist binding after nigrostriatal denervation: evidence for early and drastic changes in the rat corpus striatum.
    Feuerstein C; Demenge P; Caron P; Barrette G; Guerin B; Mouchet P
    Brain Res; 1981 Dec; 226(1-2):221-34. PubMed ID: 7296288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]spiperone binding in the nigrostriatal system in human brain.
    Ruberg M; Bokobza B; Javoy-Agid F; Montfort JC; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):159-65. PubMed ID: 6203765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic D-3 binding sites are not presynaptic autoreceptors.
    Leff SE; Creese I
    Nature; 1983 Dec 8-14; 306(5943):586-9. PubMed ID: 6417548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat.
    Paturle L; Fage D; Fourrier O; Vernier P; Feuerstein C; Demenge P; Scatton B
    Brain Res; 1987 Feb; 402(2):383-6. PubMed ID: 3828803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat.
    Neve KA; Marshall JF
    Neurosci Lett; 1984 Apr; 46(1):77-83. PubMed ID: 6203067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
    Traub M; Wagner HR; Hassan M; Jackson-Lewis V; Fahn S
    Eur J Pharmacol; 1985 Nov; 118(1-2):147-54. PubMed ID: 3936723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.
    Nielsen EB; Nielsen M; Braestrup C
    Psychopharmacology (Berl); 1983; 81(1):81-5. PubMed ID: 6415736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.